Research Overview: WINIMED SUSP 50 DEUS MEDICAL
WINIMED SUSP 50 is a stanozolol-based suspension formulation designed for sophisticated in-vitro research applications. This injectable preparation contains 50mg/ml stanozolol in a precisely engineered aqueous suspension, enabling researchers to examine anabolic compound interactions in controlled laboratory environments. Research institutions studying metabolic pathways and cellular protein synthesis mechanisms will find this formulation particularly valuable for their investigative protocols.
Stanozolol represents a synthetic derivative of dihydrotestosterone, making it an essential research tool for laboratories investigating androgenic receptor binding characteristics and downstream cellular responses. The suspension format provides researchers with enhanced solubility control compared to traditional oil-based formulations, allowing for more precise experimental dosing parameters in research models.
Laboratory Research Applications
Academic institutions frequently utilise stanozolol suspensions to investigate nitrogen retention mechanisms in cellular cultures, examining how synthetic androgens influence protein metabolism at the molecular level. Research teams studying muscle tissue development pathways have documented significant applications for this compound in understanding anabolic signalling cascades. The aqueous suspension format facilitates precise volumetric measurements essential for reproducible experimental protocols.
Comparative studies between different anabolic compounds often include stanozolol as a reference standard, particularly when investigating hepatic metabolism pathways and enzymatic interactions. Researchers examining androgenic receptor selectivity patterns find this formulation invaluable for controlled laboratory investigations. Our comprehensive selection available at Stroid UK Shop includes various research compounds for comparative analysis, alongside our stanozolol category offerings for specialised research applications.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Stanozolol |
| Concentration | 50mg/ml |
| Formulation | Aqueous suspension |
| Volume | 10ml vial |
| Manufacturer | Deus Medical |
| Storage | Room temperature |
Research laboratories may also investigate complementary compounds from our SARMs collection or peptides range for comprehensive comparative studies.
Research Compliance Statement
WINIMED SUSP 50 is manufactured exclusively for in-vitro research purposes and laboratory analysis. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. All research must comply with institutional safety protocols and applicable regulations governing laboratory research compounds.
